IP Library Granted Patent US 10,072,254
Granted Patent B2
US 10,072,254 · App. 15/232,626 · Granted Sep 11, 2018

Cell culture methods for expressing ADAMTS13 protein

Inventors: Leopold Grillberger (Vienna, AT); Alexandra Spenger (Vienna, AT); Meinhard Hasslacher (Vienna, AT); Rana Grillberger (Vienna, AT); Manfred Reiter (Vienna, AT)
Assignees: Baxalta Incorporated; Baxalta GmbH
C12N9/6489C12N5/0682C12N5/0686C12Y304/24087C12N2500/14C12N2500/22C12N2500/38C12N2500/95C12N2500/99C12N2510/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,072,254
App. No.
15/232,626
Granted
Sep 11, 2018
Kind
B2
Abstract

The present invention provides culture mediums that are useful for the expression of ADAMTS proteins, such as ADAMTS13. Methods for the expression and purification of ADAMTS proteins are also provided. In some embodiments, the mediums and methods of the invention are useful for the expression of ADAMTS proteins having high specific activities. Also provided are ADAMTS, e.g., ADAMTS13, protein compositions with high specific activities, which are expressed and purified according to the methods provided herein.

Claims (19)

1. A method for expressing a disintegrin and metalloproteinase with thrombospondin motifs 13 (ADAMTS13) protein, the method comprising culturing, by continuous cultivation, a mammalian cell harboring a nucleic acid encoding an ADAMTS13 protein in a culture medium comprising at least 3 μM zinc and at least 4 mg/L nicotinamide, wherein the continuous cultivation includes maintaining a cell density of from 1×10 6 cells/mL to 4×10 6 cells/mL for at least seven days.

2. The method of claim 1 , wherein the culture medium comprises from 3 μM to 12 μM zinc.

3. The method of claim 1 , wherein the culture medium comprises about 5 μM zinc.

4. The method of claim 1 , wherein the culture medium comprises from 4 mg/L to 10 mg/L nicotinamide.

5. The method of claim 2 , wherein the culture medium comprises from 4 mg/L to 10 mg/L nicotinamide.

6. The method of claim 3 , wherein the culture medium comprises from 4 mg/L to 10 mg/L nicotinamide.

7. The method of claim 1 , wherein the culture medium comprises about 7 mg/L nicotinamide.

8. The method of claim 2 , wherein the culture medium comprises about 7 mg/L nicotinamide.

9. The method of claim 3 , wherein the culture medium comprises about 7 mg/L nicotinamide.

10. The method of claim 1 , wherein the culture medium further comprises from 0.5 mM to 1.5 mM calcium.

11. The method of claim 5 , wherein the culture medium further comprises from 0.5 mM to 1.5 mM calcium.

12. The method of claim 9 , wherein the culture medium further comprises from 0.5 mM to 1.5 mM calcium.

13. The method of claim 1 , wherein the mammalian cell is selected from the group consisting of a CHO cell, a BHK cell, and an HEK cell.

14. The method of claim 5 , wherein the mammalian cell is selected from the group consisting of a CHO cell, a BHK cell, and an HEK cell.

15. The method of claim 9 , wherein the mammalian cell is selected from the group consisting of a CHO cell, a BHK cell, and an HEK cell.

16. The method of claim 1 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

17. The method of claim 5 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

18. The method of claim 9 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

19. The method of claim 14 , wherein the ADAMTS13 protein is a human ADAMTS13 protein.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055188/0953 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2018
From: GRILLBERGER, LEOPOLD; SPENGER, ALEXANDRA; HASSLACHER, MEINHARD; GRILLBERGER, RANA; REITER, MANFRED
To: BAXTER HEALTHCARE SA; BAXTER INTERNATIONAL INC.
Reel/Frame 044805/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2018
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 045244/0233 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2018
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 045250/0001 →
Continuity (6)
Continuation 14807745 · Jul 23, 2015
Continuation 14276819 · May 13, 2014
Continuation 13622939 · Sep 19, 2012
Continuation 12847999 · Jul 30, 2010
Provisional Application 61230477 · Jul 31, 2009
Related Publication 20170051270A1 · Feb 23, 2017